Access to drugs for treatment of noncommunicable diseases.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 23935456.
- Also identified by DOI 10.1371/journal.pmed.1001485 and PMC identifier 3720246.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Thomas Bollyky explains the emerging controversy over patented medicines for noncommunicable diseases and their affordability in developing countries. Another transformation in global health is required that focuses on low-cost interventions and patient-centered, rather than country-focused, strategies. <i>Please see later in the article for the Editors' Summary</i>
Medical subject headings
- Developing Countries
- Global Health
- Health Services Accessibility
- Patents as Topic
- Pharmaceutical Preparations